Hydrazino-type radionuclide chelators having an N.sub.3 S config

Details Hydrazino-type radionuclide chelators having an N.sub.3 S config Hydrazino-type radionuclide chelators having an N.sub.3 S config

1994-09-02

1997-08-19

Hollinden, Gary E.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

546153, 546139, 546141, 546159, 546156, 546143, 534 10, 534 14, 5303915, 564310, 564226, 544180, 544239, 544240, 544194, C07D21377, C07D21380, C07D23720, C07D23942

Patent

active

056590415

ABSTRACT:
Radionuclide chelating compounds are provided for conjugation to targeting molecules such as proteins, peptides or antibodies. The resulting labeled targeting molecules may be used in diagnosis and therapy.

REFERENCES:
patent: 4732864 (1988-03-01), Tolman
patent: 4849511 (1989-07-01), Verbruggen
patent: 4861869 (1989-08-01), Nicolotti et al.
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4965392 (1990-10-01), Fritzberg et al.
patent: 4980147 (1990-12-01), Fritzberg et al.
patent: 5037630 (1991-08-01), Fritzberg et al.
patent: 5082930 (1992-01-01), Nicolotti et al.
patent: 5089249 (1992-02-01), Fritzberg et al.
patent: 5091514 (1992-02-01), Fritzberg et al.
patent: 5095111 (1992-03-01), Lever et al.
patent: 5112594 (1992-05-01), Woulfe et al.
patent: 5112595 (1992-05-01), Woulfe et al.
patent: 5112953 (1992-05-01), Gustavson et al.
patent: 5120526 (1992-06-01), Fritzberg et al.
patent: 5175257 (1992-12-01), Kasina et al.
patent: 5175343 (1992-12-01), Fritzberg et al.
patent: 5187264 (1993-02-01), Verbruggen
patent: 5196515 (1993-03-01), Lever et al.
patent: 5202451 (1993-04-01), Fritzberg et al.
Dewanjee, "The Chemistry of .sup.99m Tc-labeled Radiopharmaceuticals", Seminars in Nuclear Medicine, vol. XX;5-27, (1990).
Green et al., "Gallium Radiopharmaceutical Chemistry", Nucl. Med. Biol. vol. 16:435-448, (1989).
Brenner et al., "Synthesis And Characterization Of A Series Of Isomeric Oxotechnetium(V) Diamido Dithiolates", Inorg. Chem., vol. 23:3793-3797, (1984).
Cotysyfakis et al., "Indium-111-labeled Cationic Complexes Of Aminothiols", Eur. J. Nucl. Med., vol. 20:302-307, (1993).
Eckelman et al., "Three Approaches To Radiolabeling Antibodies With .sup.99m Tc", Nucl. Med. Biol., vol. 16(2):171-176, (1989).
Fischman et al., "Imaging Focal Sites Of Bacterial Infection In Rats With Indium-111-labeled Chemotactic Peptide Analogs", J. Nucl. Med., vol. 32:483-494, (1991).
Fritzberg et al., "Approaches To Radiolabeling Of Antibodies For Diagnosis And Therapy Of Cancer", Pharmaceutical Res., vol. 5(6):325-334. (1988).
Olsen, "Synthesis Of Quinoxaline Peptides By The Solid Phase Method", J. Heterocycl. Chem., vol. 7(2):435-437, (1970).
Paik et al., "The Labeling Of High Affinity Sites Of Antibodies With .sup.99m Tc", Int. J. Nucl. Med. Biol., vol. 12:3-8, (1985).
Schneider et al., "N,N'-bis(S-benzoylmercaptoacetamido) Ethylenediamine And Propylenediamine Ligands As Renal Function Imaging Agents", J. Nucl. Med., vol. 25:223-229, (1984).

Affiliated with

Also associated with

Rating

Hydrazino-type radionuclide chelators having an N.sub.3 S config does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydrazino-type radionuclide chelators having an N.sub.3 S config, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrazino-type radionuclide chelators having an N.sub.3 S config will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1105804